Table 2.
Multivariate analyses
| OS | PFS | ||||||
|---|---|---|---|---|---|---|---|
| Parameter | Reference | p value | HR | 95% confidence interval | p value | HR | 95% confidence interval |
| T-stage | |||||||
| T3/4 | T1/2 | 0.633 | 0.8 | 0.3–2.1 | 0.454 | 0.7 | 0.3–1.8 |
| T2 + 1 | T1/2 | 0.388 | 0.6 | 0.2–1.9 | 0.346 | 0.6 | 0.2–1.8 |
| Chemotherapy | No chemotherapy | 0.017 | 0.4 | 0.2–0.8 | 0.070 | 0.5 | 0.2–1.1 |
| Charlson index | No comorbidities | 0.897 | 1.1 | 0.5–2.5 | 0.647 | 1.2 | 0.5–2.8 |
| Age | 0.060 | 1.0 | 1.0–1.1 | 0.049 | 1.1 | 1.0–1.1 | |
| BMI | |||||||
| Underweight | Normal weight | 0.062 | 2.5 | 1.0–6.7 | 0.004 | 3.9 | 1.5–9.8 |
| Overweight | 0.426 | 1.3 | 0.7–2.5 | 0.530 | 1.2 | 0.6–2.4 | |
| Obese | 0.978 | 1.0 | 0.4–2.2 | 0.680 | 1.2 | 0.5–2.7 |
1T2 + was used for tumors stages at least T2 but without further exact T-staging